353810 — Easy Bio Cashflow Statement
0.000.00%
Last trade - 00:00
- KR₩127bn
- KR₩183bn
- KR₩165bn
- 74
- 79
- 72
- 92
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final |
Net Income/Starting Line | 10,425 | 10,842 | 9,347 | 16,101 |
Depreciation | ||||
Amortisation | ||||
Non-Cash Items | 4,424 | 4,744 | 4,711 | 2,734 |
Unusual Items | ||||
Equity in Net Earnings/Losses | ||||
Other Non-Cash Items | ||||
Changes in Working Capital | -78.1 | -4,321 | -25,945 | 11,158 |
Change in Accounts Receivable | ||||
Change in Inventories | ||||
Change in Other Assets | ||||
Change in Accounts Payable | ||||
Change in Other Liabilities | ||||
Net Change in Other Assets & Liabilities | ||||
Other Operating Cash Flow | ||||
Cash from Operating Activities | 16,465 | 14,066 | -8,124 | 33,684 |
Capital Expenditures | -1,215 | -1,839 | -2,049 | -1,965 |
Purchase of Fixed Assets | ||||
Purchase / Acquisition of Intangibles | ||||
Other Investing Cash Flow Items | 690 | -18,221 | 2,563 | -39,375 |
Sale of Fixed Assets | ||||
Sale/Maturity of Investment | ||||
Purchase of Investments | ||||
Other Investing Cash Flow | ||||
Cash from Investing Activities | -525 | -20,060 | 514 | -41,340 |
Financing Cash Flow Items | -17 | 0 | — | — |
Other Financing Cash Flow | ||||
Total Cash Dividends Paid | ||||
Net Issuance / Retirement of Stock | ||||
Net Issuance / Retirement of Debt | ||||
Cash from Financing Activities | -433 | 6,229 | 27,878 | -3,408 |
Foreign Exchange Effects | ||||
Beginning Cash Balance | ||||
Ending Cash Balance | ||||
Net Change in Cash | 15,499 | 255 | 19,209 | -10,844 |